ABSTRACT Listeriosis outbreaks are frequently multistate/multicountry outbreaks, underlining the importance of molecular typing data for several diverse and wellcharacterized isolates. Large-scale whole-genome sequencing studies on Listeria monocytogenes isolates from non-U.S. locations have been limited. Herein, we describe the draft genome sequences of 510 L. monocytogenes isolates from northern Italy from different sources.
L
isteria monocytogenes is a Gram-positive foodborne bacterial pathogen primarily responsible for listeriosis in humans. Cases of listeriosis, which are caused by the consumption of several different types of contaminated foods, can be sporadic or part of an outbreak (1) . Given the frequent multistate or multinational nature of listeriosis outbreaks, it is important to have a large amount of molecular typing data for well-characterized isolates obtained from several different sources and countries (1, 2) . In the United States, L. monocytogenes isolates from foods and clinical cases have been routinely analyzed with whole-genome sequencing (WGS) since 2013 (2) . However, a large part of non-U.S. isolates are those implicated in known international outbreaks, and large-scale WGS data for isolates from non-U.S. locations are currently somewhat limited. Herein, we describe the draft genome sequences of 510 L. monocytogenes isolates from northern Italy from different sources.
A total of 416 L. monocytogenes isolates were collected from different nonclinical sources (i.e., foods and food-processing environments, feeds, animal tissues, and stools) in Piedmont in northern Italy between 2003 and 2014. Additionally, we included 94 isolates from human clinical cases spanning from 2002 to 2016 and originating from the same geographical area in northern Italy. DNA extraction was performed with the DNeasy blood and tissue kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. DNA libraries were prepared with the Nextera XT DNA library preparation kit. WGS was carried out on a MiSeq or a NextSeq system using a 2 ϫ 250-bp or a 2 ϫ 150-bp paired-end MiSeq/NextSeq reagent kit, respectively (Illumina, San Diego, CA, USA). De novo genome assemblies were created using CLC Genomics Workbench 10 (CLC bio, Aarhus, Denmark), and assembled genomes were annotated using the National Center for Biotechnology Information (NCBI) Prokaryotic Genome Annotation Pipeline (https://www.ncbi.nlm.nih.gov/genome/annotation_prok/). Multilocus sequence typing (MLST) (http://bigsdb.pasteur.fr/listeria/listeria.html) and multivirulence locus sequence typing (MVLST) (https://sites.google.com/site/mvlstdatabase/) were car-ried out according to available schemes to assign sequence types (STs) or virulence types (VTs), respectively.
Overall, there were 52 STs and 45 VTs. Some profiles were found in only clinical (9 STs, 6 VTs) or food/environmental (24 STs, 18 VTs) isolates. One profile (VT11, associated with ST9/ST204), was observed across different sources and years and represented 36% of all sequenced isolates. Interestingly, in 28 food/environmental isolates, the tet (n ϭ 1) or the tet(M) (n ϭ 27) gene was detected, representing a prevalence of 5.49%. This appears to be higher than what was recently reported (0.6%) for 1,143 L. monocytogenes isolates collected in the European Union from ready-to-eat foods and human clinical cases (3) .
The draft genome sequences described herein will be useful in (i) comparative genomic analyses of L. monocytogenes from different locations and periods and (ii) supporting epidemiological investigations of outbreaks. A future publication will describe the genomic features of these strains in more detail. Accession number(s). The genome assemblies described in this paper are available in DDBJ/EMBL/GenBank under the accession numbers listed in Table 1 .
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